(S)-1-Boc-2-(Hydroxymethyl)piperazine

Catalog No.: 
ACAUQN458
CAS No.: 
1030377-21-9
Molecular Formula: 
C10H20N2O3
Molecular Weight: 
216.28
(S)-1-Boc-2-(Hydroxymethyl)piperazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$72.00In stockIn stock
25g98%$256.00In stockIn stock
100g98%$1022.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-1-Boc-2-(Hydroxymethyl)piperazine
IUPAC Nametert-butyl (S)-2-(hydroxymethyl)piperazine-1-carboxylate
MDL No.MFCD07772093
Molecular FormulaC10H20N2O3
Molecular Weight216.28
SMILESOC[C@H]1N(C(OC(C)(C)C)=O)CCNC1
InChI KeyBCPPNDHZUPIXJM-QMMMGPOBSA-N
SynonymCS-D0657 | AC-33626 | (S)-1-N-BOC-2-HYDROXYMETHYLPIPERAZINE | 1030377-21-9 | SCHEMBL1990452 | (S)-1-Boc-2-hydroxymethyl-piperazine, AldrichCPR | tert-butyl (2S)-2-(hydroxymethyl)piperazine-1-carboxylate | (S)-1-Boc-(2-Hydroxymethyl)piperazine | (S)-1-Boc-
CAS No.1030377-21-9
PubChem CID22884145

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAUQN458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDOVM187 route compound structure diagram
    ACDOVM187385802-84-6In Stock
  2. Then
  3. ACAUQN458 route product structure diagram
    ACAUQN4581030377-21-9In Stock
Inquiry

2. ACAUQN458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJSDH179 route compound structure diagram
    ACJSDH179159532-59-9In Stock
  2. Then
  3. ACAUQN458 route product structure diagram
    ACAUQN4581030377-21-9In Stock
Inquiry

3. ACAUQN458 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAUQN458 route product structure diagram
    ACAUQN4581030377-21-9In Stock
Inquiry

Comments (0)